Survivor’s Ethan Zohn Becomes Trulieve’s Momenta Ambassador

Trulieve Cannabis (TSE: TRUL) announced Monday it has entered into an exclusive partnership with cancer survivor and Survivor: Africa winner Ethan Zohn. Through this partnership, Zohn will be the official brand ambassador for Momenta, Trulieve’s in-house cannabis brand.

Pick the best stocks and maximize your portfolio:

Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks

Zohn said that as a two-time cancer survivor and stem cell transplant recipient, cannabis, CBD and herbal wellness have been instrumental in his physical and mental recovery.

Patient Education and Community Outreach Initiatives

Zohn will document and share his holistic wellness journey with cannabis and how he incorporates cannabis into his daily routine.

The former professional footballer will also wear Momenta clothing during his future sporting activities. Zohn’s first role as brand ambassador will be at the grand opening of Trulieve’s dispensary in Framingham, Mass., which is coming soon.

Momenta cannabis, currently available in Florida, Massachusetts and West Virginia, enables patients to enhance their daily wellness routines.

CEO Commentary

Trulieve CMO Valda Coryat said, “Trulieve is excited to partner with Ethan as we expand our brand presence and identify partnerships aligned with the values of our patients and the communities we serve. Ethan’s personal wellness journey will inspire and educate patients around the country, and we are pleased to work with him to initiate engaging conversations around cannabis’ holistic benefits.”

Wall Street’s Take

On February 28, Craig-Hallum analyst Eric Des Lauriers kept a Buy rating on TRUL and lowered its price target to $60 (C$76.49). This implies 223.2% upside potential.

Overall, consensus on the Street is that TRUL is a Strong Buy based on six Buys. The average Trulieve Cannabis price target of C$77.08 implies 225.9% upside potential to current levels.

Download the TipRanks mobile app now

To find good ideas for stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a tool that unites all of TipRanks’ equity insights.